The healthy exocrine pancreas contains preproinsulin-specific CD8 T cells that attack islets in type 1 diabetes

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC)..

Preproinsulin (PPI) is presumably a crucial islet autoantigen found in patients with type 1 diabetes (T1D) but is also recognized by CD8+ T cells from healthy individuals. We quantified PPI-specific CD8+ T cells within different areas of the human pancreas from nondiabetic controls, autoantibody-positive donors, and donors with T1D to investigate their role in diabetes development. This spatial cellular quantitation revealed unusually high frequencies of autoreactive CD8+ T cells supporting the hypothesis that PPI is indeed a key autoantigen. To our surprise, PPI-specific CD8+ T cells were already abundantly present in the nondiabetic pancreas, thus questioning the dogma that T1D is caused by defective thymic deletion or systemic immune dysregulation. During T1D development, these cells accumulated in and around islets, indicating that an islet-specific trigger such as up-regulation of major histocompatibility complex class I might be essential to unmask beta cells to the immune system.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:6

Enthalten in:

Science advances - 6(2020), 42 vom: 17. Okt.

Sprache:

Englisch

Beteiligte Personen:

Bender, Christine [VerfasserIn]
Rodriguez-Calvo, Teresa [VerfasserIn]
Amirian, Natalie [VerfasserIn]
Coppieters, Ken T [VerfasserIn]
von Herrath, Matthias G [VerfasserIn]

Links:

Volltext

Themen:

61116-24-3
Autoantigens
Insulin
Journal Article
Preproinsulin
Protein Precursors
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 13.04.2022

Date Revised 13.04.2022

published: Electronic-Print

Citation Status MEDLINE

doi:

10.1126/sciadv.abc5586

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM316366862